Ameren Corporation AEE
Verdict: Sell. Fair value $85.20 against a price of $101 on 5 Jan 2026, 16% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power.
The case against: In 2023, Revenue declined 5.8% ($7.96B to $7.50B) while Net Income increased 7.5% ($1.07B to.... Average EPS surprise is exactly +0.0% over recent quarters, with a beat rate of 75%. This level of.... Input data lacks Operating Cash Flow and Balance Sheet items (Assets, Inventory, Receivables),....
Main risks
- CRITICAL: Missing Balance Sheet data prevents leverage and return on capital analysis
- Revenue Volatility: 2024 revenue ($7.62B) remains below 2022 peak ($7.96B)
- Growth Stagnation: 1.6% YoY revenue growth lags inflation and sector targets
- In 2023, Revenue declined 5.8% ($7.96B to $7.50B) while Net Income increased 7.5% ($1.07B to...
- Input data lacks Operating Cash Flow and Balance Sheet items (Assets, Inventory, Receivables),...
- In 2023, Revenue declined 5.8% ($7.96B to $7.50B) while Net Income increased 7.5% ($1.07B to $1.15B), indicating earnings growth was driven by margin expansion (likely rate cases or cost cuts) rather than top-line demand.